The aim of this study was to investigate the association between pre‐diagnostic circulating concentrations of IGF‐I and risk of overall bladder cancer and urothelial cell carcinoma (UCC) using a case–control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. The gene discussed is IGF1; the disease is transitional cell carcinoma.